Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copies of newspaper advertisements in the following newspaper: 1. Business Standard on February 11,2020 2. Mumbai Lakhsdeep on February 11,2020 Lasa Supergenerics Ltd - 540702 - Financial Results For The Quarter Ended December 31,2019
The Board of Directors in their meeting held today at the Corporate Office of the Company have considered, approved and took on record the Unaudited Financial Results for the quarter and nine months ended December 31,2019. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to provisions of Regulation 47(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith, copies of the newspaper advertisements in respect of Board Meeting, scheduled to be held on Monday, February 10, 2020 and published in the following Newspapers 1. Business Standard on February 2, 2020; and 2. Mumbai Lakshdeep on February 2, 2020. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Quarterly Results For The Quarter Ended December 31, 2019
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2020 ,inter alia, to consider and approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter ended December 31, 2019 Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended December 31, 2019
Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here Lasa Supergenerics Ltd - 540702 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Lasa Supergenerics Ltd has submitted to BSE a copy of Clarification is enclosed. Lasa Supergenerics Ltd - 540702 - Clarification sought from Lasa Supergenerics Ltd
The Exchange has sought clarification from Lasa Supergenerics Ltd on 10th January, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nidhi kulshresthaDesignation :- Company Secretary and Compliance Officer Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. January 01, 2020 till 72 hours after the declaration of financial results (both days inclusive) for the quarter ended on December 31, 2019.